HY-138632-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
HY-138633-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9]
|
|
Cancer-programmed cell death
|
|
HY-138633-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9]
|
|
Cancer-programmed cell death
|
|
HY-138633-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-10 [CAS 2417370-49-9]
|
|
Cancer-programmed cell death
|
|
HY-138635-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0]
|
|
Cancer-programmed cell death
|
|
HY-138635-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0]
|
|
Cancer-programmed cell death
|
|
HY-138635-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0]
|
|
Cancer-programmed cell death
|
|
HY-148870-10mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-100mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-25mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-5mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-50mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-153524-1mg
|
MedChemexpress LLC
|
ATTO 425 NHS ester [CAS 892156-28-4]
|
|
|
|
HY-15941-100mg
|
MedChemexpress LLC
|
5(6)-FITC [CAS 27072-45-3]
|
|
|
|
HY-15941-500mg
|
MedChemexpress LLC
|
5(6)-FITC [CAS 27072-45-3]
|
|
|
|
HY-15943-10mg
|
MedChemexpress LLC
|
6-TAMRA [CAS 91809-67-5]
|
|
|
|
HY-15943-25mg
|
MedChemexpress LLC
|
6-TAMRA [CAS 91809-67-5]
|
|
|
|
HY-15943-5mg
|
MedChemexpress LLC
|
6-TAMRA [CAS 91809-67-5]
|
|
|
|
HY-15943-50mg
|
MedChemexpress LLC
|
6-TAMRA [CAS 91809-67-5]
|
|
|
|
HY-46572-10mg
|
MedChemexpress LLC
|
Benzyl 2-cyclopropyl-2-hydroxyacetate [CAS 182747-31-5]
|
|
|
|
HY-46572-25mg
|
MedChemexpress LLC
|
Benzyl 2-cyclopropyl-2-hydroxyacetate [CAS 182747-31-5]
|
|
|
|
HY-46572-5mg
|
MedChemexpress LLC
|
Benzyl 2-cyclopropyl-2-hydroxyacetate [CAS 182747-31-5]
|
|
|
|
HY-46572-50mg
|
MedChemexpress LLC
|
Benzyl 2-cyclopropyl-2-hydroxyacetate [CAS 182747-31-5]
|
|
|
|
HY-66019-100mg
|
MedChemexpress LLC
|
FITC [CAS 3326-32-7]
|
|
|
|
HY-66019-10mL/1mL
|
MedChemexpress LLC
|
FITC [CAS 3326-32-7]
|
|
|
|